Literature DB >> 31073736

Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease.

Mirabella Zhao1, Johan Burisch2.   

Abstract

Crohn's disease and ulcerative colitis constitute two major subgroups of inflammatory bowel diseases (IBD), a group of complex polygenic diseases characterized by chronic and progressive inflammation in the gastrointestinal tract. In recent years, methodological advances in genetic analysis have greatly expanded our understanding of the genetic background of IBD. So far, more than 240 genetic risk loci have been identified for IBD. However, these risk alleles explain less than 30% of the susceptibility to disease development, suggesting that environmental factors contribute considerably. The increasing occurrence of IBD in Eastern countries following their 'westernization', as well as the increased risk of disease among those who migrate to high-incidence regions, also suggest that the environment is key in the pathogenesis of IBD. In this review, we summarize the current evidence on the role of genetic and environmental factors in the susceptibility to, and disease course of, IBD, and we suggest how these findings might be applied to clinical practice.

Entities:  

Keywords:  Crohn’s disease; Environment; Genetics; Inflammatory bowel disease; Pathogenesis; Risk factors; Ulcerative colitis

Mesh:

Year:  2019        PMID: 31073736     DOI: 10.1007/s10620-019-05648-w

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  89 in total

Review 1.  Detecting shared pathogenesis from the shared genetics of immune-related diseases.

Authors:  Alexandra Zhernakova; Cleo C van Diemen; Cisca Wijmenga
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

2.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.

Authors:  Jeffrey C Barrett; Sarah Hansoul; Dan L Nicolae; Judy H Cho; Richard H Duerr; John D Rioux; Steven R Brant; Mark S Silverberg; Kent D Taylor; M Michael Barmada; Alain Bitton; Themistocles Dassopoulos; Lisa Wu Datta; Todd Green; Anne M Griffiths; Emily O Kistner; Michael T Murtha; Miguel D Regueiro; Jerome I Rotter; L Philip Schumm; A Hillary Steinhart; Stephan R Targan; Ramnik J Xavier; Cécile Libioulle; Cynthia Sandor; Mark Lathrop; Jacques Belaiche; Olivier Dewit; Ivo Gut; Simon Heath; Debby Laukens; Myriam Mni; Paul Rutgeerts; André Van Gossum; Diana Zelenika; Denis Franchimont; Jean-Pierre Hugot; Martine de Vos; Severine Vermeire; Edouard Louis; Lon R Cardon; Carl A Anderson; Hazel Drummond; Elaine Nimmo; Tariq Ahmad; Natalie J Prescott; Clive M Onnie; Sheila A Fisher; Jonathan Marchini; Jilur Ghori; Suzannah Bumpstead; Rhian Gwilliam; Mark Tremelling; Panos Deloukas; John Mansfield; Derek Jewell; Jack Satsangi; Christopher G Mathew; Miles Parkes; Michel Georges; Mark J Daly
Journal:  Nat Genet       Date:  2008-06-29       Impact factor: 38.330

Review 3.  The innate immune system and inflammatory bowel disease.

Authors:  Julie M Davies; Maria T Abreu
Journal:  Scand J Gastroenterol       Date:  2015-01       Impact factor: 2.423

4.  Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease.

Authors:  M Orholm; K Fonager; H T Sørensen
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

5.  Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011.

Authors:  Frederik Trier Moller; Vibeke Andersen; Jan Wohlfahrt; Tine Jess
Journal:  Am J Gastroenterol       Date:  2015-03-24       Impact factor: 10.864

6.  Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.

Authors:  D Franchimont; S Vermeire; H El Housni; M Pierik; K Van Steen; T Gustot; E Quertinmont; M Abramowicz; A Van Gossum; J Devière; P Rutgeerts
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

7.  Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.

Authors:  Isabelle Cleynen; Juan R González; Carolina Figueroa; Andre Franke; Dermot McGovern; Martin Bortlík; Bart J A Crusius; Maurizio Vecchi; Marta Artieda; Magdalena Szczypiorska; Johannes Bethge; David Arteta; Edgar Ayala; Silvio Danese; Ruud A van Hogezand; Julian Panés; Salvador Amado Peña; Milan Lukas; Derek P Jewell; Stefan Schreiber; Severine Vermeire; Miquel Sans
Journal:  Gut       Date:  2012-12-21       Impact factor: 23.059

8.  CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease.

Authors:  T Heliö; L Halme; M Lappalainen; H Fodstad; P Paavola-Sakki; U Turunen; M Färkkilä; T Krusius; K Kontula
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

9.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.

Authors:  Andre Franke; Dermot P B McGovern; Jeffrey C Barrett; Kai Wang; Graham L Radford-Smith; Tariq Ahmad; Charlie W Lees; Tobias Balschun; James Lee; Rebecca Roberts; Carl A Anderson; Joshua C Bis; Suzanne Bumpstead; David Ellinghaus; Eleonora M Festen; Michel Georges; Todd Green; Talin Haritunians; Luke Jostins; Anna Latiano; Christopher G Mathew; Grant W Montgomery; Natalie J Prescott; Soumya Raychaudhuri; Jerome I Rotter; Philip Schumm; Yashoda Sharma; Lisa A Simms; Kent D Taylor; David Whiteman; Cisca Wijmenga; Robert N Baldassano; Murray Barclay; Theodore M Bayless; Stephan Brand; Carsten Büning; Albert Cohen; Jean-Frederick Colombel; Mario Cottone; Laura Stronati; Ted Denson; Martine De Vos; Renata D'Inca; Marla Dubinsky; Cathryn Edwards; Tim Florin; Denis Franchimont; Richard Gearry; Jürgen Glas; Andre Van Gossum; Stephen L Guthery; Jonas Halfvarson; Hein W Verspaget; Jean-Pierre Hugot; Amir Karban; Debby Laukens; Ian Lawrance; Marc Lemann; Arie Levine; Cecile Libioulle; Edouard Louis; Craig Mowat; William Newman; Julián Panés; Anne Phillips; Deborah D Proctor; Miguel Regueiro; Richard Russell; Paul Rutgeerts; Jeremy Sanderson; Miquel Sans; Frank Seibold; A Hillary Steinhart; Pieter C F Stokkers; Leif Torkvist; Gerd Kullak-Ublick; David Wilson; Thomas Walters; Stephan R Targan; Steven R Brant; John D Rioux; Mauro D'Amato; Rinse K Weersma; Subra Kugathasan; Anne M Griffiths; John C Mansfield; Severine Vermeire; Richard H Duerr; Mark S Silverberg; Jack Satsangi; Stefan Schreiber; Judy H Cho; Vito Annese; Hakon Hakonarson; Mark J Daly; Miles Parkes
Journal:  Nat Genet       Date:  2010-12       Impact factor: 38.330

10.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  12 in total

1.  Inverse and Concordant Mucosal Pathway Gene Expressions in Inflamed and Non-Inflamed Ulcerative Colitis Patients: Potential Relevance to Aetiology and Pathogenesis.

Authors:  Jan Söderman; Linda Berglind; Sven Almer
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

Review 2.  Bench to bedside - new insights into the pathogenesis of necrotizing enterocolitis.

Authors:  David J Hackam; Chhinder P Sodhi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-28       Impact factor: 73.082

3.  Polystyrene microplastics induce an immunometabolic active state in macrophages.

Authors:  Seth D Merkley; Harrison C Moss; Samuel M Goodfellow; Christina L Ling; Jewel L Meyer-Hagen; John Weaver; Matthew J Campen; Eliseo F Castillo
Journal:  Cell Biol Toxicol       Date:  2021-05-22       Impact factor: 6.691

4.  Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells.

Authors:  Rhonda M Brand; Beverley A Moore; Ashley Zyhowski; Aaron Siegel; Shikhar Uttam; E Jeffrey Metter; Jarret Engstrom; Randall E Brand; Nabanita Biswas; David C Whitcomb; David G Binion; Marc Schwartz; Ian McGowan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-12-23       Impact factor: 4.052

5.  Inflammatory Bowel Diseases and Parkinson's Disease.

Authors:  Tomasz Brudek
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

6.  Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy-the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study.

Authors:  Mirabella Zhao; Flemming Bendtsen; Andreas Munk Petersen; Lone Larsen; Anders Dige; Christian Hvas; Jakob Benedict Seidelin; Johan Burisch
Journal:  BMJ Open       Date:  2020-02-25       Impact factor: 2.692

7.  Sphingosine-1-phosphate signal transducer and activator of transcription 3 signaling pathway contributes to baicalein-mediated inhibition of dextran sulfate sodium-induced experimental colitis in mice.

Authors:  Jing Yao; Tao Liu; Rui-Jiao Chen; Jing Liang; Jun Li; Chuan-Gong Wang
Journal:  Chin Med J (Engl)       Date:  2020-02-05       Impact factor: 2.628

Review 8.  Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?

Authors:  Lihui Lin; Gaoshi Zhou; Peng Chen; Ying Wang; Jing Han; Minhu Chen; Yao He; Shenghong Zhang
Journal:  Cell Death Dis       Date:  2020-06-15       Impact factor: 8.469

Review 9.  Precision medicine in inflammatory bowel disease: concept, progress and challenges.

Authors:  Simon P Borg-Bartolo; Ray Kiran Boyapati; Jack Satsangi; Rahul Kalla
Journal:  F1000Res       Date:  2020-01-28

10.  Mapping global research trends in stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019.

Authors:  Yuming Chong; Chang Han; Ji Li; Xiao Long
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.